Base Year
Historical Year
Forecast Year
The global hydroxychloroquine and chloroquine market size attained a value of USD 1.84 million in 2023, driven by its rising application in the treatment of malaria. The market is anticipated to grow at a CAGR of 8.5% during the forecast period of 2024-2032, likely to attain a value of USD 3.85 million by 2032.
Hydroxychloroquine and chloroquine are antimalarial medicines that are used to treat malaria. These medicines were frequently used by healthcare professionals during the COVID-19 pandemic as these were showing positive results in treating the virus when no other medicines were working. Other than coronavirus, the increased cases of malaria got these drugs to get popular especially around pandemic. Hydroxychloroquine is generally used in the treatment of autoimmune diseases, such as rheumatoid arthritis and systematic lupus erythematosus.
SLE Hydroxychloroquine helps in enhancing the performance of immune system and reduces inflammation as well. Chloroquine has been in existence from a long time, but it was never given such important before the pandemic. Chloroquine drug is generally used in treating malaria but it protects patients against malaria caused from parasite. It does so by stopping the growth of malarial parasite in the human body.
Due to the high demand for hydroxychloroquine and chloroquine drugs, especially during the COVID-19 pandemic, the rate of manufacturing of these drugs has increased in the last few years. Additionally, due to the discovery of these drugs as a potential treatment for coronavirus, there are many research going on to explore the potential of hydroxychloroquine and chloroquine in other medical conditions as well. Owing to the several research still being in process, the governments have put certain safety guidelines over the regulation and consumptions of these drugs, such as no consumption should be performed without a consultation with a healthcare professional. The potential rise in the use of the medication in the treatment of other diseases is anticipated to propel the hydroxychloroquine and chloroquine market expansion.
Market Breakup by Strength
Market Breakup by Grade
Market Breakup by Dosage Form
Market by Route of Administration
Hydroxychloroquine and Chloroquine Market Breakup by Applications
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
The increased demand for the drugs, owing to its application in the treatment of malaria and especially in the treatment of coronavirus, has been primarily driving the demand. There are specific guidelines regarding the usage of hydroxychloroquine and chloroquine by the government as there are multiple research that are being conducted to validate the fact that they might actually be effective in other medical conditions other than malaria and COVID-19. The hydroxychloroquine and chloroquine drug market development has been running steadily but ever since COVID-19 happened, there has been a huge surge in the demand for these drugs in the global market. The global hydroxychloroquine and chloroquine market is expected to grow in coming years as well.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Strength |
|
| Breakup by Grade |
|
| Breakup by Dosage Form |
|
| Breakup by Route of Administration |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of USD 1.84 million in 2023, driven by its rising uses in the treatment of malaria.
The market size is anticipated to grow at a CAGR of 8.5% during the forecast period of 2024-2032, likely to attain a value of USD 3.85 million by 2032.
The growth of the market is driven by factors like rising healthcare sector, rising investment by the government in healthcare development, and the rising use of the drug in malaria treatment, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The different strengths of these drugs in the market are 100mg, 200mg, 250mg, and 500mg.
The different grades in the global market are USP standards grade, EP standards grade, and pharmaceutical standards grade, among others.
The different forms of dosages are injectables and tablets.
The different applications in the market are rheumatoid arthritis, malaria, and COVID-19, among others.
The different route of administration in the market includes oral and intravenous.
The different end users are hospitals, specialty clinics, and homecare, among others.
The different distribution channels in the market are hospital pharmacy, retail pharmacy, and online pharmacy, among others.
The governments have put certain safety guidelines over the regulation and consumptions of these drugs, which is a key trend for the market.
Key players involved in the market are Ipca Laboratories Ltd., Zydus Cadila, Novartis AG, Teva Pharmaceutical Industries Ltd., Bayer AG, Rising Pharma Holdings Inc., Abcam plc., Mylan N.V., Abbott Laboratories, Artecef B.V., Uniprix Inc., and Recipharm.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share